 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
CD4+ Cell Assays
Overview
- Measuring CD4 and CD8 Cell Counts: Why Are They Done? (Regularly Updated)
From aidsmap.com - Review of CD4 Technologies (PDF)
From Forum for Collaborative HIV Research - CD4 Commercially Available Assays Summary (PDF) (August 30, 2004)
From Forum for Collaborative HIV Research - Measuring Memory T-Cell Responses (Winter 2001/2002)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
Research
- Study Confirms Importance of CD4 Increase, Undetectable Viral Load After Starting HAART (March 28, 2008)
From aidsmap.com - Normal Values of CD4 and CD8 Lymphocyte Subsets in Healthy Indian Adults and the Effects of Sex, Age, Ethnicity, and Smoking (March 2008)
In IAPAC Monthly, from International Association of Physicians in AIDS Care - CD4+ Cell Percentage Predicts HIV Disease Progression (February 1, 2007)
In Journal of Infectious Diseases - CD4 Lymphocyte Percentage Predicts Disease Progression in HIV-Infected Patients Initiating Highly Active Antiretroviral Therapy With CD4 Lymphocyte Counts >350 Lymphocytes/mm3 (October 2005)
Abstract of a study in the Sept. 15, 2005 issue of the Journal of Infectious Diseases.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - To Start or Not to Start? CD4 Percentage May Provide Guidance (August 29, 2005)
Among people with a CD4 count above 350, HIV disease progression is found to be 3.6 times more likely for those with a CD4 percentage below 17%.
From aidsmap.com - The Buzz: The Disconnect Syndrome -- A Controversial Dilemma (May/June 2002)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network - CD4+ Cell Percentage May Aid Treatment Decision for Patients With Good CD4+ Cell Count
Among patients with a CD4+ cell count above 350, disease progression is found to be 3.6 times more likely for those with a CD4+ cell percentage below 17%.
In Journal of Infectious Diseases
Substitutes for CD4+ Cell Assays in Resource-Poor Areas
- EasyCD4 Low-Cost CD4 Cell Assay as Accurate as Current Gold Standard (May 26, 2006)
From aidsmap.com - PLoS Medicine Articles Discuss Simple CD4 Testing in Developing Countries (July 27, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Predicting CD4+ Cell Counts Where There Are None (July/August 2005)
In resource-poor areas, TLC cutoffs and anemia may serve as surrogate markers for the need to start HIV treatment.
From The Body PRO - PointCare: A CD4+ Cell Test for Resource-Limited Settings (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - CD4 Monitoring in Resource-Limited Settings: The State of the Art at AIDS 2004 (July/August 2004)
A summary of recent research on low-cost substitutes for conventional CD4 counts.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Total Lymphocyte Count Monitoring Can Be a Lower-Cost Surrogate for CD4 Count Monitoring Following Initiation of HAART (July 2004)
Abstract of a study published in JAIDS.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Less Expensive HIV Progression Test as Effective as Current Tests in Use (November 22, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Prices of CD4 Assays and Viral Load Tests Must Be Reduced for Developing Countries (October 6, 2001)
In British Medical Journal
  |
  |